Navigation Links
Mount Sinai leads program of excellence in nanotechnology with $16.5 million grant
Date:9/29/2010

in preventing the progression of heart disease and improve the safety and efficacy of existing treatments."

In addition to the pioneering research aims of the PEN Center at Mount Sinai, the Center will institute a unique training program focused on developing translational nanomedical tools for diagnostic imaging and minimally invasive treatment of cardiovascular disease. Furthering Mount Sinai's ongoing commitment to translational research, the program will stress the importance of bringing the discoveries made as a result of the contract to the patient care setting.

"We are honored to have been selected as one of the primary investigation sites for the PEN program," said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of Mount Sinai School of Medicine and Executive Vice President for Academic Affairs at The Mount Sinai Medical Center. "The goals for this program embody Mount Sinai's unwavering commitment to translational research, and will open doors for our world-renowned physician-scientists to make significant advances in preventing and treating cardiovascular disease."

In addition to Dr. Fayad, the Mount Sinai project leaders are Valentin Fuster, MD, PhD, Director of Mount Sinai Heart, the Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josee and Henry R. Kravis Center for Cardiovascular Health; Roger Hajjar, MD, Research Director of the Wiener Family Cardiovascular Research Laboratories and the Arthur & Janet Ross Professor of Cardiology, Medicine, and Gene and Cell Medicine; and Martin Schwartz, PhD, Assistant Professor of Cardiology and Medicine. Other Mount Sinai investigators participating in the program are Willem Mulder, PhD, David Cormode, PhD, Kevin Costa, PhD, and Hina Chaudhry, MD. The other institutions involved in this grant are New York University, Columbia University, Brigham and Women's Hospital, and the Massachusetts Institute of Technology.

"Cardiovascular disease impacts millions
'/>"/>

Contact: Mount Sinai Press Office
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. In-Room Computers and Wall-Mounted Proximity Systems Computer WorkStations Deliver Increased Efficiency; Improved Patient Care
2. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
3. AlloSource Distributes Record Amount of Tissue in 2008
4. Proximity Systems LAN Based Electronic Lock Management System Offers Increased Security, Efficiency and Reporting Capability for Wall-Mounted WorkStations
5. ViroPharma Improves Financial Position Through Repurchase of $45 Million Principal Amount of Senior Convertible Notes
6. New Generation Biofuels Signs Sales Contract with Catoctin Mountain Growers to Supply up to 370,000 gallons of Renewable Biofuel
7. Biologist discovers pink-winged moth in Chiricahua Mountains
8. TransTech Services Partners, Inc. Shareholders Approve Plan of Liquidation; Company To Distribute Amounts in Trust
9. Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes
10. Surface Mount Solutions Launches New Website
11. Amount of gene surplus determines severity of mental retardation in males
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... , ... Since the initial launch of FireflySci Inc. (FFS) in early 2015, the company continues ... Images such as the Fonz in a lab coat and Large Marge have been posted ... field. , FireflySci is proud to be the only cuvette manufacturer is the ...
(Date:8/27/2015)... ... ... Capital Edge Consulting , a nationwide consulting firm that specializes in helping ... one of the top 5000 companies listed on the 2015 Inc. 5000 , ... is truly an honor to be recognized as one of America’s fastest growing companies. ...
(Date:8/27/2015)... TORONTO , Aug. 27, 2015 /PRNewswire/ - ... Securities Exchange: PBT.U), and Biohaven Pharmaceutical Holding Company ... in a Phase I study of BHV-0223, a ... application (IND) regarding BHV-0223 and recently obtained clearance ... to proceed with human testing. Portage holds 54% ...
(Date:8/27/2015)... MENLO PARK, Calif. , Aug. 27, 2015 /PRNewswire/ ... company in the emerging field of regenerative medicine, today ... two investor conferences in the month of September.  ... Officer, will present at Rodman & Renshaw,s 17th Annual ... 10:25am ET/7:25am PT at the St. Regis Hotel in ...
Breaking Biology Technology:Cuvette Manufacturer FireflySci Launches Back to School Deals with Complimentary Shipping On All Orders 2Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 2Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4Asterias Biotherapeutics to Present at Upcoming Investor Conferences 2
... COATED PLATE ASSAYS ... instrument for the counting of radioimmunoassays based on coated microtitration plates. The ... data presented compare the standard immunoassay microtitration plates with those manufactured by ... basic assay procedure is straightforward: , ...
... Introduction , ... brain can lead to several disease states, including anxiety, depression ... the mode of action of various transmitters, in order to ... the neurotransmitter to its receptor alters the production of the ...
... J. Watson , ... Introduction , ... resulted in an increase in the production of potential drug candidates, it ... PerkinElmer Life Sciences has provided a platform for the adaptation of a ...
Cached Biology Technology:Coated Plate Immunoassay on the MicroBeta - eg. TSH - IRMA 2In Vitro Measurement of the Second Messenger cAMP: RIA vs. FlashPlate 2In Vitro Measurement of the Second Messenger cAMP: RIA vs. FlashPlate 3In Vitro Measurement of the Second Messenger cAMP: RIA vs. FlashPlate 4Use of Novel FlashPlate Technology to Measure cAMP Accumulation in Chinese Hamster Ovary Cells Expressing Human -2 Adrenoreceptors 2Use of Novel FlashPlate Technology to Measure cAMP Accumulation in Chinese Hamster Ovary Cells Expressing Human -2 Adrenoreceptors 3Use of Novel FlashPlate Technology to Measure cAMP Accumulation in Chinese Hamster Ovary Cells Expressing Human -2 Adrenoreceptors 4
(Date:8/25/2015)... BELLEVUE, Wash. , Aug. 25, 2015  Sarcos ... today it will unveil its "Guardian S" snake robot, ... National Tactical Officers Association Conference on August 30 in ... is the first-ever commercially available energetically autonomous snake robot, ... in-field trials and is protected by more than 50 ...
(Date:8/20/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market and creator of the Wocket® ... Alliance and the EMV Migration Forum.  ... Alliance Latin America (SCALA) Chapter provides NXT-ID, Inc. direct ... promoting adoption of smart card technology. To ...
(Date:8/12/2015)... Minn. , Aug. 12, 2015   MedNet ... supports the entire spectrum of clinical research, is proud ... , the company,s comprehensive SaaS-based eClinical technology platform, has ... during the first two quarters of 2015.   Q2 ... second largest quarters measured by contract value sold in ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4MedNet Solutions Experiences Explosive Corporate Growth 2
... Reseachers at The Ohio State University have demonstrated that ... method for preserving the important genetic diversity of ornamental ... some of the most popular flowers the world. So ... more than 3,000 varieties of geranium in their 2004 ...
... of scientists today in an advanced online publication in the ... background of the type of lung cancer that is the ... Of particular interest was a specific proto-oncogene called NKX2-1 ... lung adenocarcinomas the most common cause of cancer ...
... Northeast Biofuel Summit, Nov. 11-13, at the Statler Hotel ... regions current biomass inventory, including agricultural feedstock designated for ... to diversify and expand biofuel feedstocks (those plants which ... participants will assess the Northeasts ability to meet its ...
Cached Biology News:'TRAP' preserves genetic properties of popular geranium 2Tumor genome analysis unveils new insights into lung cancer 2Tumor genome analysis unveils new insights into lung cancer 3
...
Request Info...
Human RUNX2/CBFA1 MAb (Clone 232902)...
... Streptavidin-Horseradish Peroxidase Conjugate, 2 ... reporter enzyme molecules for ... in situ hybridization applications.High ... & Labeling & Detection, ...
Biology Products: